Acetylcholine and bradykinin enhance hypotension and affect the function of remodeled conduit arteries in SHR and SHR treated with nitric oxide donors

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 6, 2005, Pages 959-966

  Gerová, Maria ^a   Kristek, F ^a   Cacanyiova S ^a   Cebova M ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Conduit iliac artery; Hypertension; Iliac artery; Molsidomine; Pentaerythritol tetranitrate; Resistance arteries; Structure

Indexed keywords

ACETYLCHOLINE; BRADYKININ; MOLSIDOMINE; NITRIC OXIDE DONOR; PENTAERYTHRITYL TETRANITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL WALL; CAROTID ARTERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG POTENTIATION; HYPERTENSION; HYPOTENSION; ILIAC ARTERY; IN VITRO STUDY; JUGULAR VEIN; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 21744437353     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000600019     Document Type: Article

References (37)

1. Rees DD, Palmer RHJ, Schulz R, Hodson HF & Moncada S (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 101: 746-752.
2. Hwa JJ, Ghibaudi L, Williams P & Chatterjee M (1994). Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. American Journal of Physiology, 266: H952-H958.
3. Török J & Kristek F (2002). Beneficial effect of pentaerythritol tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition. Vascular Pharmacology, 38: 177-182.
4. Gerová M, Mesároš Š, Kristek F, Kittová M & Malinski T (1998). NO concentration in the periendothelial area of the femoral artery of the dog measured in vivo. Physiological Research, 47: 169-175.
5. G-nitro-L-arginine methyl ester. British Journal of Pharmacology, 101: 632-639.
6. Zanchi A, Aubert JF, Brunner HR & Waeber B (1995). Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro. Cardiovascular Research, 30: 122-129.
7. G-nitro-L-arginine in anesthetized rats. Clinical and Experimental Pharmacology and Physiology, 25: 510-516.
8. Gerová M (1999). Acetylcholine and bradykinin induce paradoxically amplified hypotensive response in hypertensive NO-deficient rats. Physiological Research, 48: 249-257.
9. Gerová M & Kristek F (2001). Efficiency of NO donors in substituting the impaired endogeous NO production. Functional and morphological study. Physiological Research, 50: 165-173.
10. Kristek F (2000). Pentaerythritol tetranitrate could prevent structural changes in conduit arteries evoked by long-term NO-synthase inhibition. British Journal of Pharmacology, 130: 450-456.
11. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. British Journal of Pharmacology, 102: 823-826.
12. Arnal J-F, Battle T, Ménard J & Michel J-B (1993). The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rat. Journal of Hypertension, 11: 945-950.
13. Kristek F (1998). Long-term administration of L-arginine did not influence blood pressure, heart rate, cardiac hypertrophy or arterial wall thickness of spontaneously hypertensive rats. Experimental Physiology, 83: 595-603.
14. Pourageaud F & Freslon J-L (1995). Impaired endothelial relaxations induced by agonists and flow in spontaneously hypertensive rat compared to Wistar-Kyoto rat perfused coronary arteries. Journal of Vascular Research, 32: 190-199.
15. Liu H, Ledingham JM, Mullaney I & Laserty R (2002). Endothelial function in mesenteric resistance arteries from genetically hypertensive rat. Clinical and Experimental Pharmacology and Physiology, 29: 405-411.
16. Ravingerová T, Šimončíková P, Strnisková M, Barančík M, Ziegelhoffer A & Gerová M (2003). Tolerance to cardiac ischemia/reperfusion injury is modulated in hypertensive rats with chronic NO deficiency. Experimental and Clinical Cardiology, 8: 47 (Abstract).
17. Albrecht I (1974). The hemodynamics of early stages of spontaneous hypertension in rats. Japanese Circulation Journal, 38: 985-990.
18. Smith TL & Hutchins PM (1979). Central hemodynamics in the developmental stage of spontaneous hypertension in the anesthetized rat. Hypertension, 1: 508-517.
19. Yamamoto J, Nakai M & Natsume T (1987). Cardiovascular responses to acute stress in young-to-old spontaneously hypertensive rats. Hypertension, 9: 362-370.
20. Dück KD & Richard F (1990). Langzeitnitrattherapie bei koronarer Herzkrankheit - Wirkungsverlust durch Toleranzentwicklung? (Long-term therapy of coronary artery disease - loss of efficacy through development of tolerance?). Zeitschrift für die Gesamte Innere Medizin, 24: 736-741.
21. Fink B & Bassenge E (1997). Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythritol tetranitrate. Journal of Cardiovascular Pharmacology, 30: 831-836.
22. Oberle S, Schwartz P, Abate A & Schroder H (1999). The antioxidant defense protein ferritin is a novel and specific target for pentaerythritol tetranitrate in endothelial cells. Biochemical and Biophysical Research Communications, 261: 28-34.
23. Matsumoto M (1969). Morphological studies on the nervous system of spontaneously hypertensive rat. Fluorescence microscopical observations on the superior cervical sympathetic ganglia of SHR. Japanese Circulation Journal, 33: 411-416.
24. Head RJ (1989). Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels, 26: 1-20.
25. Korner P, Bobik A, Oddie C & Friberg P (1993). Sympathoadrenal system is critical for structural changes in genetic hypertension. Hypertension, 22: 243-252.
26. Mertens MJ, Batink HD, Mathy MJ, Pfaffendorn M & van Zwieten PA (1995). Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy. Journal of Autonomic Pharmacology, 15: 465-474.
27. Granstam SO, Granstam E, Follstrom B & Lind L (1998). Effects of acetylcholine and nitroprusside on systemic and regional hemodynamics in hypertensive rats. Clinical and Experimental Hypertension, 20: 223-243.
28. Chang HR, Lee RP, Wu CY & Chen HI (2002). Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clinical and Experimental Pharmacology and Physiology, 29: 275-280.
29. Qiu HY, Henrion D, Benessiano J, Heymes C, Tournier B & Levy BI (1998). Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats. Hypertension, 32: 1098-1103.
30. Mayhan WG (1990). Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. American Journal of Physiology, 259: H1455-H1462.
31. Addicks K, Bloch W & Feelisch M (1994). Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microscopy Research and Technique, 29: 161-168.
32. Laughlin MH, Turk JR, Schrage WG, Woodman CR & Price EM (2003). Influence of coronary artery diameter on eNOS protein content. American Journal of Physiology, 284: H1307-H1312.
33. Kimura C, Oike M, Ohnaka K, Nosey Y & Ito Y (2004). Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study. Journal of Physiology, 554: 721-730.
34. Malinski T, Kapturczak M, Dayharsh J & Bohr D (1993). Nitric oxide synthase activity in genetic hypertension. Biochemical and Biophysical Research Communications, 194: 654-658.
35. Feletou M & Vanhoutte PM (2000). Endothelium-dependent hyperpolarization of vascular smooth muscle cells. Acta Pharmacologica Sinica, 21: 1-18.
36. Kristek F, Fáberová V & Varga I (2003). Long-term effect of molsidomine and pentaerythritol tetranitrate on cardiovascular system of spontaneously hypertensive rats. Physiological Research, 52: 709-717.
37. Gerová M, Gero J, Doležel S & Blažková-Huzuláková I (1973). Sympathetic control of canine abdominal aorta. Circulation Research, 33: 149-159.